{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T23:19:40Z","timestamp":1772493580230,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"am","delay-in-days":355,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.medmal.2019.10.010","type":"journal-article","created":{"date-parts":[[2019,11,10]],"date-time":"2019-11-10T07:18:05Z","timestamp":1573370285000},"page":"537-544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Management of oral antiretroviral administration in patients with swallowing disorders or with an enteral feeding tube"],"prefix":"10.1016","volume":"50","author":[{"given":"Carine","family":"San","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.P.","family":"L\u00ea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Matheron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Mourvillier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Caseris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-F.","family":"Timsit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Yazdanpanah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Descamps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Peytavin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.medmal.2019.10.010_bib0310","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1007\/s00134-014-3481-7","article-title":"Temporal trends in critical events complicating HIV infection: 1999-2010 multicentre cohort study in France","volume":"40","author":"Barbier","year":"2014","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.medmal.2019.10.010_bib0315","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1513\/pats.201009-060WR","article-title":"Critical Illness in HIV-Infected Patients in the Era of Combination Antiretroviral Therapy","volume":"8","author":"Akg\u00fcn","year":"2011","journal-title":"Proc Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.medmal.2019.10.010_bib0320","doi-asserted-by":"crossref","first-page":"R107","DOI":"10.1186\/cc9056","article-title":"Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era","volume":"14","author":"Coquet","year":"2010","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.medmal.2019.10.010_bib0325","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1378\/chest.08-0980","article-title":"Survival for patients With HIV admitted to the ICU continues to improve in the current era of combination antiretroviral therapy","volume":"135","author":"Powell","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.medmal.2019.10.010_bib0330","unstructured":"ANSM. Nutritional support strategy for protein-energy malnutrition in the elderly [Internet]. 2007. Available from: https:\/\/www.has-sante.fr\/portail\/upload\/docs\/application\/pdf\/malnutrition_elderly_guidelines.pdf."},{"issue":"8","key":"10.1016\/j.medmal.2019.10.010_bib0335","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.rmr.2011.09.007","article-title":"Swallowing disorders, pneumonia and respiratory tract infectious disease in the elderly","volume":"28","author":"Puisieux","year":"2011","journal-title":"Revue des maladies respiratoires"},{"key":"10.1016\/j.medmal.2019.10.010_bib0340","series-title":"HIV-Related Pill Aversion: A Novel Barrier to Adherence, poster abstract 469. Conference on Retroviruses and Opportunistic Infections","author":"Dorman","year":"2017"},{"key":"10.1016\/j.medmal.2019.10.010_bib0345","unstructured":"European AIDS Clinical Society. Guidelines version 9.0, October 2017 [Internet]. Available from: http:\/\/www.eacsociety.org\/files\/guidelines_9.0-english.pdf. Last accessed July 1, 2018."},{"key":"10.1016\/j.medmal.2019.10.010_bib0350","unstructured":"Morlat P (dir.). Initiation d\u2019un premier traitement antir\u00e9troviral. In: Prise en charge medicale des personnes vivant avec le VIH. Recommandations du groupe d\u2019experts, sous la direction du Pr Philippe Morlat et sous l\u2019\u00e9gide du CNS et de l\u2019ANRS [Internet]. 2017. Available from: https:\/\/cns.sante.fr\/wp-content\/uploads\/2017\/01\/experts-vih_initiation.pdf. Last accessed July 1, 2018"},{"key":"10.1016\/j.medmal.2019.10.010_bib0355","unstructured":"AIDSinfo. Information on HIV\/AIDS Treatment, Prevention and Research [Internet]. 2018. Available from: https:\/\/aidsinfo.nih.gov\/. Last accessed July 1, 2018"},{"key":"10.1016\/j.medmal.2019.10.010_bib0360","unstructured":"FDA. Office of the Commissioner. U.S. Food and Drug Administration [Internet]. 2018. Available from: http:\/\/www.fda.gov. Last accessed July 1, 2018"},{"key":"10.1016\/j.medmal.2019.10.010_bib0365","unstructured":"EMA. European public assessment reports [Internet]. 2017. Available from: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/landing\/epar_search.jsp&mid=WC0b01ac058001d125. Last accessed July 1, 2018"},{"key":"10.1016\/j.medmal.2019.10.010_bib0370","unstructured":"ESPEN [Internet]. 2018. Available from: https:\/\/www.espen.org\/. Last accessed July 1, 2018"},{"key":"10.1016\/j.medmal.2019.10.010_bib0375","unstructured":"ASPEN [Internet]. 2018. Available from: https:\/\/www.nutritioncare.org\/. Last accessed July 1, 2018"},{"key":"10.1016\/j.medmal.2019.10.010_bib0380","unstructured":"Malnutrition and Nutritional Care in the UK - BAPEN [Internet]. 2018. Available from: https:\/\/www.bapen.org.uk\/. Last accessed July 1, 2018"},{"key":"10.1016\/j.medmal.2019.10.010_bib0385","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 - Portail HAS Professionnels [Internet]. 2018. Available from: https:\/\/www.has-sante.fr\/. Last accessed July 1, 2018"},{"key":"10.1016\/j.medmal.2019.10.010_bib0390","author":"Department of Health and Human Services","year":"2017","journal-title":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents"},{"issue":"6","key":"10.1016\/j.medmal.2019.10.010_bib0395","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/COH.0b013e328312c392","article-title":"Toxicity of HIV protease inhibitors: clinical considerations","volume":"3","author":"Boesecke","year":"2008","journal-title":"Curr Opin HIV AIDS"},{"issue":"7","key":"10.1016\/j.medmal.2019.10.010_bib0400","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/hiv.12475","article-title":"An oral formulation of efavirenz-loaded lactoferrin nanoparticles with improved biodistribution and pharmacokinetic profile","volume":"18","author":"Kumar","year":"2017","journal-title":"HIV Med"},{"issue":"24","key":"10.1016\/j.medmal.2019.10.010_bib0405","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.2146\/ajhp120106","article-title":"Administration of antiretroviral medication via enteral tubes","volume":"69","author":"Prohaska","year":"2012","journal-title":"Am J Health Syst Pharm"},{"issue":"Suppl. 4","key":"10.1016\/j.medmal.2019.10.010_bib0410","doi-asserted-by":"crossref","first-page":"P114","DOI":"10.1186\/1758-2652-13-S4-P114","article-title":"Administration of darunavir tablets in patients with difficulties in swallowing\u2013two case reports","volume":"13","author":"Scholten","year":"2010","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"10.1016\/j.medmal.2019.10.010_bib0415","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4212\/cjhp.v67i1.1321","article-title":"Orogastric administration of crushed darunavir tablets for a critically ill patient","volume":"67","author":"Kim","year":"2014","journal-title":"Can J Hosp Pharm"},{"issue":"3","key":"10.1016\/j.medmal.2019.10.010_bib0420","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3851\/IMP2708","article-title":"Relative bioavailability of a paediatric granule formulation of the HIV integrase inhibitor dolutegravir in healthy adult subjects","volume":"19","author":"Patel","year":"2014","journal-title":"Antivir Ther (Lond)"},{"issue":"12","key":"10.1016\/j.medmal.2019.10.010_bib0425","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1128\/AAC.00942-12","article-title":"Comparison of the in vivo pharmacokinetics and in vitro dissolution of raltegravir in HIV patients receiving the drug by swallowing or by chewing","volume":"56","author":"Cattaneo","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2019.10.010_bib0430","unstructured":"ANSM. Foscavir: R\u00e9sum\u00e9 des caract\u00e9ristiques du produit. 2017"},{"key":"10.1016\/j.medmal.2019.10.010_bib0435","unstructured":"ANSM. Retrovir: R\u00e9sum\u00e9 des caract\u00e9ristiques du produit. 2017"},{"issue":"2","key":"10.1016\/j.medmal.2019.10.010_bib0440","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/2325957417692678","article-title":"Enteral Administration of Twice-Daily Dolutegravir and Rilpivirine as a Part of a Triple-Therapy Regimen in a Critically Ill Patient with HIV","volume":"16","author":"Turley","year":"2017","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"10.1016\/j.medmal.2019.10.010_bib0445","series-title":"Bioequivalence of Two Pediatric Formulations vs. Adult Tablet Formulation of Elvitegravir, poster abstract 902. Conference on Retroviruses and Opportunistic Infections","author":"Custodio","year":"2014"},{"issue":"5","key":"10.1016\/j.medmal.2019.10.010_bib0450","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1097\/QAI.0b013e31820eefbe","article-title":"A randomized crossover study to determine relative bioequivalence of tenofovir, emtricitabine, and efavirenz (Atripla) fixed-dose combination tablet compared with a compounded oral liquid formulation derived from the tablet","volume":"56","author":"King","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.medmal.2019.10.010_bib0455","series-title":"Crushing of dolutegravir combination tablets increases dolutegravir exposure, poster abstract 429. Conference on Retroviruses and Opportunistic Infections","author":"Roskam-Kwint","year":"2017"},{"key":"10.1016\/j.medmal.2019.10.010_bib0460","doi-asserted-by":"crossref","DOI":"10.1097\/QAI.0000000000001296","article-title":"Pharmacokinetics of Crushed Elvitegravir Combination Tablet Given with or without Enteral Nutrition","author":"Jongbloed-de Hoon","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"10.1016\/j.medmal.2019.10.010_bib0465","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2146\/ajhp130737","article-title":"Sustained virological response after taking crushed elvitegravir-cobicistat-emtricitabine- tenofovir tablets","volume":"71","author":"Fulco","year":"2014","journal-title":"American Journal of Health-System Pharmacy"},{"key":"10.1016\/j.medmal.2019.10.010_bib0470","series-title":"Relative Bioavailability of Darunavir\/Cobicistat\/Emtricitabine\/Tenofovir Alafenamide (D\/C\/F\/TAF) Single-Tablet Regimen When Administered as a Whole, Split, or Crushed Tablet, Oral abstract PS8\/3. 16th European AIDS Conference","author":"Brown","year":"2017"},{"issue":"5","key":"10.1016\/j.medmal.2019.10.010_bib0475","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/135965350601100501","article-title":"Foscarnet salvage therapy for patients with late-stage HIV disease and multiple drug resistance","volume":"11","author":"Canestri","year":"2006","journal-title":"Antivir Ther (Lond)"},{"issue":"3","key":"10.1016\/j.medmal.2019.10.010_bib0480","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.phclin.2015.03.001","article-title":"Le broyage des comprim\u00e9s, l\u2019ouverture des capsules, quelles responsabilit\u00e9s?","volume":"50","author":"Arnaud","year":"2015","journal-title":"Le Pharmacien Hospitalier et Clinicien"},{"issue":"3","key":"10.1016\/j.medmal.2019.10.010_bib0485","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ddes.2012.07.002","article-title":"La dispensation des m\u00e9dicaments","volume":"12","author":"Devers","year":"2012","journal-title":"Droit, D\u00e9ontologie & Soin"},{"key":"10.1016\/j.medmal.2019.10.010_bib0490","unstructured":"France. French Public Health Code, Article R4311-7. French Public Health Code"},{"issue":"8","key":"10.1016\/j.medmal.2019.10.010_bib0495","first-page":"463","article-title":"\u00c9crasement des m\u00e9dicaments en g\u00e9riatrie: Mise au point et recommandations de bonnes pratiques","author":"Barry Perdereau","year":"2015","journal-title":"La Revue De G\u00e9riatrie"},{"issue":"10","key":"10.1016\/j.medmal.2019.10.010_bib0500","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.revmed.2012.05.014","article-title":"Crushing drugs in geriatric units: an \u201chandicraft\u201d practice with frequent errors which imposed recommendations","volume":"33","author":"Caussin","year":"2012","journal-title":"Rev Med Interne"},{"issue":"21","key":"10.1016\/j.medmal.2019.10.010_bib0505","first-page":"12","article-title":"Medication errors in patients with dysphagia","volume":"108","author":"Kelly","year":"2012","journal-title":"Nurs Times"},{"key":"10.1016\/j.medmal.2019.10.010_bib0510","unstructured":"France. French Public Health Code, Article L5121-12-1. French Public Health Code"},{"key":"10.1016\/j.medmal.2019.10.010_bib0515","unstructured":"France. French Public Health Code, Article R4235-48. French Public Health Code"},{"key":"10.1016\/j.medmal.2019.10.010_bib0520","unstructured":"France. French Public Health Code, Article R4235-61. French Public Health Code"},{"key":"10.1016\/j.medmal.2019.10.010_bib0525","unstructured":"BAPEN. Administering drugs via enteral feeding tubes: a practical guide [Internet]. 2004. Available from: http:\/\/www.bapen.org.uk\/pdfs\/d_and_e\/de_pract_guide.pdf. Last accessed July 1, 2018"},{"key":"10.1016\/j.medmal.2019.10.010_bib0530","unstructured":"Liverpool Drug Interactions Group. Antiretroviral dosage forms for swallowing difficulties [Internet]. 2017. Available from: https:\/\/liverpool-web-production.s3.amazonaws.com\/printable_charts\/pdfs\/000\/000\/028\/original\/ARV_Swallowing_2017_Apr.pdf?1512034916. Last accessed July 1, 2018"},{"key":"10.1016\/j.medmal.2019.10.010_bib0535","unstructured":"Foisy M, Hughes C, Lamb S, Tseng A. Oral antiretroviral administration: information on crushing and liquid drug formulations [Internet]. 2017. Available from: https:\/\/hivclinic.ca\/main\/drugs_extra_files\/Crushing%20and%20Liquid%20ARV%20Formulations.pdf. Last accessed July 1, 2018"},{"issue":"1","key":"10.1016\/j.medmal.2019.10.010_bib0540","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1293.2007.00426.x","article-title":"Once-daily nevirapine dosing: a pharmacokinetics, efficacy and safety review","volume":"8","author":"Cooper","year":"2007","journal-title":"HIV Med"},{"issue":"2","key":"10.1016\/j.medmal.2019.10.010_bib0545","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/0148607108330314","article-title":"Enteral nutrition practice recommendations","volume":"33","author":"Bankhead","year":"2009","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"1","key":"10.1016\/j.medmal.2019.10.010_bib0550","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/0148607116673053","article-title":"ASPEN Safe Practices for Enteral Nutrition Therapy","volume":"41","author":"Boullata","year":"2017","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.medmal.2019.10.010_bib0555","series-title":"Handbook of drug administration via enteral feeding tubes","first-page":"569","author":"White","year":"2007"},{"issue":"24","key":"10.1016\/j.medmal.2019.10.010_bib0560","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.2146\/ajhp080155","article-title":"Medication administration through enteral feeding tubes","volume":"65","author":"Williams","year":"2008","journal-title":"Am J Health Syst Pharm"},{"issue":"4","key":"10.1016\/j.medmal.2019.10.010_bib0565","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.nupar.2013.09.009","article-title":"Administration des m\u00e9dicaments oraux chez le patient b\u00e9n\u00e9ficiant d\u2019une nutrition ent\u00e9rale","volume":"27","author":"Neuville","year":"2013","journal-title":"Nutrition Clinique et M\u00e9tabolisme"},{"key":"10.1016\/j.medmal.2019.10.010_bib0570","unstructured":"Institute for Safe Medication Practices. Oral syringes: A crucial and economical risk-reduction strategy that has not been fully utilized [Internet]. 2009. Available from: https:\/\/www.ismp.org\/newsletters\/acutecare\/articles\/20091022.asp. Last accessed July 1, 2018"},{"issue":"22","key":"10.1016\/j.medmal.2019.10.010_bib0575","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ count-guided interruption of antiretroviral treatment","volume":"355","author":"Strategies for Management of Antiretroviral Therapy (SMART) Study Group","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.medmal.2019.10.010_bib0580","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/QAD.0b013e3282f2d760","article-title":"Fixed duration interruptions are inferior to continuous treatment in African adults starting therapy with CD4 cell counts <200 cells\/microl","volume":"22","author":"DART Trial Team.","year":"2008","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.medmal.2019.10.010_bib0585","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1468-1293.2007.00436.x","article-title":"Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death","volume":"8","author":"Holkmann Olsen","year":"2007","journal-title":"HIV Med"},{"issue":"18","key":"10.1016\/j.medmal.2019.10.010_bib0590","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1097\/01.aids.0000194807.81917.50","article-title":"Determinants of HIV drug resistance mutations in plasma virus after treatment interruption","volume":"19","author":"Chilton","year":"2005","journal-title":"AIDS"},{"issue":"18","key":"10.1016\/j.medmal.2019.10.010_bib0595","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2146\/ajhp140575","article-title":"Alternative antiretroviral therapy formulations for patients unable to swallow solid oral dosage forms","volume":"72","author":"Duggan","year":"2015","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"10.1016\/j.medmal.2019.10.010_bib0600","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/PHAR.1015","article-title":"Acceptable plasma concentrations of raltegravir and etravirine when administered by gastrostomy tube in a patient with advanced multidrug-resistant human immunodeficiency virus infection","volume":"32","author":"Sandkovsky","year":"2012","journal-title":"Pharmacotherapy"},{"issue":"11","key":"10.1016\/j.medmal.2019.10.010_bib0605","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/phar.1835","article-title":"A HAART-Breaking Review of Alternative Antiretroviral Administration: Practical Considerations with Crushing and Enteral Tube Scenarios","volume":"36","author":"Huesgen","year":"2016","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.medmal.2019.10.010_bib0610","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/0148607108314770","article-title":"Quantifying amount of adsorption of levothyroxine by percutaneous endoscopic gastrostomy tubes","volume":"32","author":"Manessis","year":"2008","journal-title":"JPEN J Parenter Enteral Nutr"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X19310625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X19310625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:18:52Z","timestamp":1759972732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X19310625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":61,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0399077X19310625"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2019.10.010","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of oral antiretroviral administration in patients with swallowing disorders or with an enteral feeding tube","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2019.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}